Drugmakers’ deal making will plow ahead despite antitrust scrutiny, analysts say
July 12, 2023 at 15:59 PM EDT
Big pharma goes shopping as "patent cliff" puts more than $225 billion in revenues at risk.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|